These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Anti-arrhythmia and antifibrillatory properties of dibenzazepine derivatives].
    Author: Senova ZP, Lyskovtsev VV, Grigor'eva EK, Gorbunova VV, Kaverina NV.
    Journal: Kardiologiia; 1986 Aug; 26(8):24-8. PubMed ID: 3761845.
    Abstract:
    Antiarrhythmic and antifibrillation properties of bonnecor, a derivative of dibenzepin, were studied in comparison with ethmozine, quinidine and novocainamide, using various experimental arrhythmia models. Bonnecor activity was somewhat smaller than that of ethmozine, and much greater than that of quinidine and novocainamide in the mixed atrioventricular arrhythmia model simulated in aconitin-treated rats and the ventricular arrhythmia model simulated by two-degree coronary occlusion in dogs. Intravenous 1 mg/kg and oral 6 mg/kg bonnecor doses prevented ventricular fibrillation caused by acute coronary occlusion in rats, while ethmozine showed no such effect.
    [Abstract] [Full Text] [Related] [New Search]